By

An experimental vaccine to protect people against H7N9 avian influenza prompted immune responses in 59 percent of volunteers who received two injections at the lowest dosage tested, but only if the vaccine...

By

The Sabin Vaccine Institute (Sabin) announced recently that its product development partnership (Sabin PDP) successfully completed a Phase 1 clinical trial in Brazil of Na-GST-1/Alhydrogel®, a vaccine...

By

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances...

The World Health Organization (WHO) Thursday recommended changes to the influenza vaccine composition for the 2015 influenza season (southern hemisphere winter), which includes replacing the A/H3N2 and...

By

Updated information for the United States 2014–15 influenza season from the the Advisory Committee on Immunization Practices (ACIP) was published last month in the Morbidity and Mortality Weekly Report...

By

PRESS RELEASE This week, a student at Georgetown University died from serogroup B meningococcal disease. Continuing reports of serogroup B cases are an important reminder that there is an unmet public...

By

The National Institutes of Health (NIH) recently awarded the first year of funding from a four-year, $1.3 million grant to the Los Angeles Biomedical Research Institute (LA BioMed) to aid in the research...

By

Expectant moms should be vaccinated for pertussis, or whooping cough, during their third trimester, according to obstetricians at Loyola University Health System. Those in close contact with the infant...

By

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) approved use of Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria...

By

Genocea Biosciences, Inc. , a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, yesterday presented data from a Phase 1 study of GEN-004, an investigational vaccine designed...